NEOMYCIN POLYMYXIN B SULFATES AND DEXAMETHASONE- neomycin sulfate, polymyxin b sulfate and dexamethasone suspension/ drops

Negara: Amerika Serikat

Bahasa: Inggris

Sumber: NLM (National Library of Medicine)

Bahan aktif:

NEOMYCIN SULFATE (UNII: 057Y626693) (NEOMYCIN - UNII:I16QD7X297), POLYMYXIN B SULFATE (UNII: 19371312D4) (POLYMYXIN B - UNII:J2VZ07J96K), DEXAMETHASONE (UNII: 7S5I7G3JQL) (DEXAMETHASONE - UNII:7S5I7G3JQL)

Tersedia dari:

Preferred Pharmaceuticals, Inc.

INN (Nama Internasional):

NEOMYCIN SULFATE

Komposisi:

NEOMYCIN 3.5 mg in 1 mL

Rute administrasi :

OPHTHALMIC

Jenis Resep:

PRESCRIPTION DRUG

Indikasi Terapi:

For steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial infection exists. Ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of corticosteroids use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. They are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns; or penetration of foreign bodies. The use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. The particular anti-infective drug in this product is active against the following common bacterial eye pathogens: Staphylococcus aureus, Escherichia coli , Haemophilus influenzae, Klebsiella/Enter

Ringkasan produk:

Neomycin and polymyxin B sulfates and dexamethasone ophthalmic suspension, USP is supplied as a sterile ophthalmic suspension in a white, low-density polyethylene (LDPE) bottle with a linear low-density polyethylene (LLDPE) extended controlled drop tip and polypropylene cap: NDC 68788-9720-5- 5 mL in 10 mL bottle Relabeled By: Preferred Pharmaceuticals Inc. KEEP OUT OF REACH OF CHILDREN. Distributed by: Bausch & Lomb Americas Inc. Bridgewater, NJ 08807 USA Manufactured by: Bausch & Lomb Incorporated Tampa, FL 33637 USA © 2022 Bausch & Lomb Incorporated or its affiliates Relabeled By: Preferred Pharmaceuticals Inc. Rev. 12/2022 9114206 (Folded) 9114306 (Flat)

Status otorisasi:

Abbreviated New Drug Application

Karakteristik produk

NEOMYCIN POLYMYXIN B SULFATES AND DEXAMETHASONE- NEOMYCIN
SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE SUSPENSION/ DROPS
PREFERRED PHARMACEUTICALS, INC.
----------
NEOMYCIN AND POLYMYXIN B SULFATES
AND DEXAMETHASONE OPHTHALMIC
SUSPENSION, USP
(STERILE)
RX ONLY
DESCRIPTION
Neomycin and polymyxin B sulfates and dexamethasone ophthalmic
suspension, USP is
a multiple dose anti-infective steroid combination in sterile
suspension form for topical
application. The chemical structure for the active ingredient,
dexamethasone, is:
ESTABLISHED NAME: dexamethasone
CHEMICAL NAME: pregna-1, 4-diene-3, 20-dione, 9-fluoro-11,17,
21-trihydroxy-16-
methyl-, (11β,16α)-.
The other active ingredients are neomycin sulfate and polymyxin B
sulfate. The
structural formula for neomycin sulfate is:
The structural formula for polymyxin B sulfate is:
EACH ML CONTAINS:ACTIVES: neomycin sulfate equivalent to neomycin 3.5
mg,
polymyxin B sulfate 10,000 units, dexamethasone 0.1%. INACTIVES:
hypromellose 2910
0.5%, sodium chloride, polysorbate 20, hydrochloric acid and/or sodium
hydroxide (to
adjust pH), purified water, benzalkonium chloride 0.004%
(preservative).
CLINICAL PHARMACOLOGY
Corticosteroids suppress the inflammatory response to a variety of
agents and they
probably delay or slow healing. Since corticosteroids may inhibit the
body’s defense
mechanism against infection, a concomitant antimicrobial drug may be
used when this
inhibition is considered to be clinically significant in a particular
case.
When a decision to administer both a corticosteroid and an
antimicrobial is made, the
administration of such drugs in combination has the advantage of
greater patient
compliance and convenience, with the added assurance that the
appropriate dosage of
both drugs is administered, plus assured compatibility of ingredients
when both types of
drugs are in the same formulation and, particularly, that the correct
volume of drug is
delivered and retained.
The relative potency of corticosteroids depends on the molecular
structure,
concentration a